Merck & Co. Inc. BDR | |
Stock Exchange | Brazilian Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
- |
Public Float |
- |
Merck & Co. Inc. | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR2.75 |
Market Cap |
EUR198.12 B |
Shares Outstanding |
2.66 B |
Public Float |
2.69 B |
Merck & Co. Inc. | |
Stock Exchange | Mexican Stock Exchange |
EPS |
MXN61.26 |
Market Cap |
MXN4.2 T |
Shares Outstanding |
2.66 B |
Public Float |
2.69 B |
Merck & Co. Inc. | |
Stock Exchange | New York Stock Exchange |
EPS |
$3.17 |
Market Cap |
$220.39 B |
Shares Outstanding |
2.57 B |
Public Float |
2.6 B |
Merck & Co. Inc. | |
Stock Exchange | Euronext Paris |
EPS |
EUR2.75 |
Market Cap |
EUR199.54 B |
Shares Outstanding |
2.66 B |
Public Float |
2.69 B |
Address |
2000 Galloping Hill Road Kenilworth New Jersey 07033 United States |
Employees | - |
Website | http://www.merck.com |
Updated | 07/08/2019 |
Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. |